Table of Contents
Chapter 1. Global Naltrexone Market Executive Summary
1.1. Global Naltrexone Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Naltrexone Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Naltrexone Market Dynamics
3.1. Market Drivers
3.1.1. Increase in Autoimmune Conditions
3.1.2. Growing Addiction of Alcohol and Opiate Drugs
3.2. Market Challenges
3.2.1. Limited Awareness in Certain Regions
3.3. Market Opportunities
3.3.1. Advances in Drug Formulations and Administration Techniques
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Naltrexone Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Naltrexone Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Naltrexone Market: Type Revenue Trend Analysis, 2022 & 2032(USD Billion)
5.2.1. 25 mg
5.2.2. 50 mg
Chapter 6. Global Naltrexone Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Naltrexone Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
6.2.1. Opioid Independence
6.2.2. Alcohol Independence
Chapter 7. Global Naltrexone Market Size & Forecasts by End-User 2022-2032
7.1. Segment Dashboard
7.2. Global Naltrexone Market: End-User Revenue Trend Analysis, 2022 & 2032(USD Billion)
7.2.1. Hospitals & Clinics
7.2.2. Rehabilitation Centers
7.2.3. Wellness Centers
7.2.4. Others (Research and Academic Institutes, etc.)
Chapter 8. Global Naltrexone Market Size & Forecasts by Region 2022-2032
8.1. North America Naltrexone Market
8.1.1. U.S. Naltrexone Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. End-User breakdown size & forecasts, 2022-2032
8.1.2. Canada Naltrexone Market
8.1.2.1. Type breakdown size & forecasts, 2022-2032
8.1.2.2. Application breakdown size & forecasts, 2022-2032
8.1.2.3. End-User breakdown size & forecasts, 2022-2032
8.2. Europe Naltrexone Market
8.2.1. U.K. Naltrexone Market
8.2.1.1. Type breakdown size & forecasts, 2022-2032
8.2.1.2. Application breakdown size & forecasts, 2022-2032
8.2.1.3. End-User breakdown size & forecasts, 2022-2032
8.2.2. Germany Naltrexone Market
8.2.2.1. Type breakdown size & forecasts, 2022-2032
8.2.2.2. Application breakdown size & forecasts, 2022-2032
8.2.2.3. End-User breakdown size & forecasts, 2022-2032
8.2.3. France Naltrexone Market
8.2.4. Italy Naltrexone Market
8.2.5. Spain Naltrexone Market
8.2.6. Rest of Europe Naltrexone Market
8.3. Asia-Pacific Naltrexone Market
8.3.1. China Naltrexone Market
8.3.1.1. Type breakdown size & forecasts, 2022-2032
8.3.1.2. Application breakdown size & forecasts, 2022-2032
8.3.1.3. End-User breakdown size & forecasts, 2022-2032
8.3.2. India Naltrexone Market
8.3.3. Japan Naltrexone Market
8.3.4. Australia Naltrexone Market
8.3.5. Rest of Asia Pacific Naltrexone Market
8.4. Latin America Naltrexone Market
8.4.1. Brazil Naltrexone Market
8.4.1.1. Type breakdown size & forecasts, 2022-2032
8.4.1.2. Application breakdown size & forecasts, 2022-2032
8.4.1.3. End-User breakdown size & forecasts, 2022-2032
8.4.2. Mexico Naltrexone Market
8.4.3. Rest of Latin America Naltrexone Market
8.5. Middle East & Africa Naltrexone Market
8.5.1. South Africa Naltrexone Market
8.5.1.1. Type breakdown size & forecasts, 2022-2032
8.5.1.2. Application breakdown size & forecasts, 2022-2032
8.5.1.3. End-User breakdown size & forecasts, 2022-2032
8.5.2. Saudi Arabia Naltrexone Market
8.5.3. Rest of Middle East & Africa Naltrexone Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Taj Pharmaceuticals
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. IVAX Paper Chemicals
9.3.3. Faran Shimi
9.3.4. AdooQ Bioscience LLC
9.3.5. Sun Pharmaceutical Industries Ltd.
9.3.6. Sanofi S.A.
9.3.7. Freedom Pharmaceuticals
9.3.8. Ascent Scientific
9.3.9. Teva Pharmaceutical Industries Ltd.
9.3.10. Mallinckrodt Pharmaceuticals
9.3.11. Olympus Corporation
9.3.12. Alkermes plc
9.3.13. Hikma Pharmaceuticals
9.3.14. Pfizer Inc.
9.3.15. Endo International plc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes